U.S. Patent Office confirms validity of Osteotech’s U.S. patent on mixtures of a radiolucent material (News-Medical-Net)
U.S. Patent Office confirms validity of Osteotech’s U.S. patent on mixtures of a radiolucent material (News-Medical-Net)
Osteotech, Inc. ( NASDAQ:OSTE ) , a leader in the emerging field of biologic solutions for regenerative medicine, announced today that the United States Patent and Trademark Office has confirmed the validity of its U.S. Patent No. 5,676,146.